After the National Institutes of Health issued an order Friday night that would dramatically reduce funding, professor ...

The No. 2 in command at the National Institutes of Health, Dr. Lawrence A. Tabak, who served as acting director of the agency ...

These actions could postpone NIH-funded clinical trials and create cash flow issues for domestic biotech companies.

Efforts by the Trump administration to drastically cut federal investments in medical research are threatening to kneecap ...

While a federal judge has paused the funding cuts, the uncertainty has researchers concerned about the future of scientific ...

A separate lawsuit filed by the state of California resulted in a temporary restraining order blocking the NIH order.

Proposed cuts by the Trump administration to a type of federal funding from the National Institutes of Health would pose a ...

The Senate narrowly confirmed Robert F Kennedy Jr, one of President Donald Trump's most disputed cabinet picks, to head the ...

On Monday, a federal judge temporarily averted disaster by halting the Trump administration’s plans to slash federal funding ...

Scientists are worried about the future of the nation’s health if these cuts, now being challenged in court, are enacted.

Dr. Lawrence Tabak, the No. 2 official at the National Institutes of Health, did not give a reason for his departure.

“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...